RAGE DIAGNOSTICS LIMITED
Executive Summary
Rage Diagnostics Limited is an early-stage biotechnology research company leveraging specialized expertise and a strategic location within Cambridge's innovation ecosystem. While it currently faces typical start-up financial constraints and market entry challenges, it holds significant growth potential through targeted R&D, strategic partnerships, and access to innovation funding. To realize this potential, the company must address capital limitations, navigate regulatory complexities, and build a diversified leadership and partnership framework.
View Full Analysis Report →Company Documents
| Date | Description |
|---|---|
| 05/06/255 June 2025 | Total exemption full accounts made up to 2024-09-30 |
| 05/06/255 June 2025 | Previous accounting period shortened from 2024-12-31 to 2024-09-30 |
| 10/02/2510 February 2025 | Previous accounting period extended from 2024-09-30 to 2024-12-31 |
| 14/11/2414 November 2024 | Confirmation statement made on 2024-09-26 with updates |
| 30/09/2430 September 2024 | Annual accounts for year ending 30 Sep 2024 |
| 27/09/2327 September 2023 | Incorporation |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company